INCY
INCYTE CORP · Services · Market cap $22.7B
Insiders sold $15.0M net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Oct 19, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$58.3M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Latest filing
Oct 19, 2026
CAGNONI PABLO J
INCYTE CORP (INCY) has 84 SEC Form 4 filings (159 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Oct 19, 2026.
Inside the rolling window, 10 insiders at INCYTE CORP reported no open-market purchases and 35 open-market sales totaling $58.3M. The most active filer is President, Global Head of R&D CAGNONI PABLO J with 9 filings. Insiders have net sold $20.4M over the trailing 6 months. The most recent open-market filing is a sale of 2,642 shares by President, Global Head of R&D CAGNONI PABLO J, dated Oct 15, 2026, worth $298K.
- Industry:Biotechnology
- CEO:William J. Meury
- Employees:2,844
- HQ:Wilmington, DE, US
- IPO:1993-11-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President, Global Head of R&D | Sale | 2,642 | $298K | Oct 19 | +0.2% | SEC ↗ | |
| President, Global Head of R&D | Sale | 23,218 | $2.8M | Sep 17 | -11.1% | SEC ↗ | |
| President, Global Head of R&D | Sale | 10,801 | $1.4M | Aug 20 | -10.8% | SEC ↗ | |
| President, Global Head of R&D | Sale | 10,803 | $1.3M | Aug 14 | -5.6% | SEC ↗ | |
| EVP & Chief Scientific Officer | Sale | 2,207 | $274K | Aug 7 | -5.9% | SEC ↗ | |
| President, Global Head of R&D | Sale | 10,640 | $1.3M | Aug 7 | -5.9% | SEC ↗ | |
Mayes Patrick AFirst in 8 months | EVP & Chief Scientific Officer | Sale | 41,899 | $5.0M | Aug 4 | -5.9% | SEC ↗ |
Mayes Patrick AFirst in 8 months | EVP & Chief Scientific Officer | Sale | 6,055 | $729K | Aug 4 | — | SEC ↗ |
CAGNONI PABLO JFirst in 4 months | President, Global Head of R&D | Sale | 15,888 | $1.9M | Aug 4 | — | SEC ↗ |
Issa Mohamed KhairieFirst in 6 months | EVP, Head of U.S. Commercial | Sale | 1,093 | $126K | Jul 20 | — | SEC ↗ |
| CMO & Head of Late-Stage Dev. | Sale | 1,877 | $215K | Jul 20 | — | SEC ↗ | |
Stein Steven HFirst in 6 months | CMO & Head of Late-Stage Dev. | Sale | 28,237 | $3.2M | Jul 16 | — | SEC ↗ |
| Principal Accounting Officer | Sale | 2,639 | $264K | Jun 8 | — | SEC ↗ | |
Tray ThomasFirst in 5 months | Principal Accounting Officer | Sale | 2,051 | $200K | May 28 | — | SEC ↗ |
Clancy Paul JFirst filing | Director | Sale | 15,000 | $1.4M | May 21 | — | SEC ↗ |
| President, Global Head of R&D | Sale | 18,667 | $1.8M | Apr 21 | — | SEC ↗ | |
| President, R&D | Sale | 18,667 | $1.8M | Mar 19 | — | SEC ↗ | |
CAGNONI PABLO JFirst filing | President, R&D | Sale | 18,668 | $1.9M | Feb 23 | — | SEC ↗ |
Issa Mohamed KhairieFirst filing | EVP, Head of US Oncology | Sale | 10,856 | $1.2M | Jan 8 | — | SEC ↗ |
| EVP & Chief Medical Officer | Sale | 15,634 | $1.6M | Jan 7 | — | SEC ↗ | |
| Principal Accounting Officer | Sale | 600 | $59K | Dec 22 | — | SEC ↗ | |
| Principal Accounting Officer | Sale | 2,774 | $277K | Dec 22 | — | SEC ↗ | |
Morrissey Michael JamesFirst filing | EVP, Head of Tech. Operations | Sale | 54,008 | $5.3M | Dec 18 | — | SEC ↗ |
Morrissey Michael JamesFirst filing | EVP, Head of Tech. Operations | Sale | 4,323 | $420K | Dec 18 | — | SEC ↗ |
Mayes Patrick AFirst filing | EVP & Chief Scientific Officer | Sale | 5,553 | $531K | Dec 12 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading INCY 17 all-time
- RRep. Robert P. BresnahanSale$1,001 - $15,0002025-05-15
- DRep. Ro KhannaSale$1,001 - $15,0002024-09-09
- DRep. Ro KhannaPurchase$1,001 - $15,0002024-03-25
- DRep. Ro KhannaSale$1,001 - $15,0002023-10-10
- DRep. Ro KhannaSale$1,001 - $15,0002023-10-02
- DRep. Ro KhannaSale$1,001 - $15,0002023-09-06
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does INCY have?
INCYTE CORP (INCY) has 84 SEC Form 4 filings (159 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Oct 19, 2026.
When was the most recent SEC Form 4 filing for INCY?
The most recent Form 4 filing for INCY on Tracefour is dated Oct 19, 2026.
Who is the most active insider at INCY?
The most active SEC Form 4 filer at INCY in the rolling window is President, Global Head of R&D CAGNONI PABLO J, with 9 filings.
What is the net insider flow at INCY over the last 6 months?
Over the trailing 180 days, insiders at INCY have net sold $20.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at INCY in the current window?
Inside the rolling window, insiders at INCY bought $0 and sold $58.3M based on SEC Form 4 filings.
Can I get alerts for INCY insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at INCYTE CORP (INCY). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
INCYTE CORP is in the Services sector.